Literature DB >> 18095809

Stability studies of binary mixtures of haloperidol and/or midazolam with other drugs for parenteral administration.

María Amparo Martínez Gómez1, Víctor Jiménez Arenas, Matilde Merino Sanjuán, María José Medina Hernández, Concepción Borrás Almenar, Víctor Jiménez Torres.   

Abstract

BACKGROUND: Haloperidol and or midazolam are frequently combined with other drugs in the same solution and infused parenterally over several days to treat symptoms. The solutions may be delivered to the home well in advance of the time of administration. Consequently, physiochemical stability of these combinations needs to be studied.
OBJECTIVE: Determine the stability and physical compatibility of binary mixtures of haloperidol with morphine, scopolamine and midazolam and binary mixtures of midazolam with scopolamine and morphine.
METHODS: Mixtures of drugs were prepared under aseptic conditions in 0.9% sodium chloride or 5% glucose at concentrations used clinically for continuous infusion and stored in synthetic polyisoprenoid containers at room temperature in the presence of light for 15 days. Chemical stability was evaluated by high pressure liquid chromatography. Physical compatibility was tested by visual inspection for evidence of precipitation and color change.
RESULTS: No changes in color, precipitation of the components, or measurable losses of volume were noted. The majority of the combinations tested were stable for 15 days (T(90) >/= 15 day). However, the mixture of haloperidol and morphine reached T(90) at 10 and 9 days. The mixture containing haloperidol and scopolamine was stable for only 1 day (T(90) </= 1 day).
CONCLUSIONS: Common combinations of medications to control symptoms are compatible when mixed in 5% glucose or 0.9% sodium chloride. However, stability over 15 days is not uniform.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095809     DOI: 10.1089/jpm.2007.0028

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  2 in total

1.  Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer.

Authors:  Seydou Sanogo; Paolo Silimbani; Raffaella Gaggeri; Romina Rossi; Lisa Elviri; Marco Maltoni; Carla Masini
Journal:  Eur J Hosp Pharm       Date:  2018-05-15

2.  Avoiding the incompatibility of peripheral parenteral nutrition solution and midazolam injection for intravenous sedation.

Authors:  Akihiko Futamura; Takashi Higashiguchi; Takeshi Chihara; Yuka Yokota; Yoshinori Itani
Journal:  Fujita Med J       Date:  2020-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.